Peptide linkers for Antibody-drug conjugates (ADCs)
Antibody-drug conjugates (ADCs) are a type of targeted cancer therapy that combines the specificity of monoclonal antibodies with the cytotoxic effects
Continue readingPeptide linkers for Antibody-drug conjugates (ADCs)